AboutSkyepharma Production SAS
Fully integrated french CDMO
Skyepharma is a key player in drug development and delivery of oral technologies serving the global pharmaceutical, biotech and consumer health industries.
Since 1996, we help our clients to offer the best drug for the benefit of the patient.
In 2016, Skyepharma became the oral business Unitof the Vectura Group of Companies(www.vectura.com)andtransformed into a fully integrated french CDMO.
In June 2021, Skyepharma becomes a newly independent CDMO looking to further growth.
Identity
- 1996 : Creation of Skyepharma
- 30 years of experience in oral solid dosage forms
- More than 110 employees including 1/4 in development department
- Located near Lyon, FRANCE
Activities
- Fully integrated CDMO since 2016
- Pharmaceutical Industry
- Food supplement Industry
- Development, Manufacturing and Packaging of classic & complex oral solid forms
Capabilities
- 40MILLIONS BLISTERS PER YEAR
- 10MILLIONS BOTTLES PER YEAR
- 150MILLIONS CAPSULES PER YEAR
- 2BILLIONS TABLETS PER YEAR
As a CDMO specialized in oral solid forms, our mission is to provide product development, manufacturing and packaging services to the healthcare industry through state-of-the-art facilities, scientific expertise and open, transparent relationships.
Our vision is Solving healthcare industry complexity.
Expert and agile french CDMO
Skyepharma is deeply committed to performance management and value creation for its clients. Our services are continuously improved to offer state-of-the-art global development, manufacturing and packaging services.
Our partners can rely on our agility and scientific expertise resulting in accelerated time to market and maximized value across all pharmaceutical lifecycle stages.
